Drug Trial Radar · NCT07217860
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Oct 30, 2025
Primary completion
Jun 2029
Study completion Aug 2029
Sponsor
- Lead sponsor
- Xenon Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
X-CEED-OLE is a Phase 3, multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner in adult participants who successfully completed an antecendent Phase 3 azetukalner bipolar depression study.
Conditions
- Bipolar Depression
- Bipolar I Disorder
- Bipolar Disorder
- Bipolar II Disorder
Interventions
AzetukalnerDrug
Azetukalner 20 mg taken orally once a day with food (with the evening meal when possible) for 52 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Severity and frequency of treatment-emergent adverse events, serious adverse events, adverse events of special interest, and events of clinical interestTime frame: From the start of treatment in the open-label extension study through 8 weeks after the last dose
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Woodland International Research Group
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Clinical Innovations, Inc, dba CITrials
Bellflower, California
ProScience Research Group
Culver City, California
Clinical Innovations, Inc
Riverside, California
PharmaSouth Research, LLC
Coral Gables, Florida
Clinical Neuroscience Solutions, LLC
Jacksonville, Florida
Central Miami Medical Institute
Miami, Florida
Clinical Neuroscience Solutions, LLC
Orlando, Florida
Synexus Clinical Research, Inc.
Atlanta, Georgia
Atlanta Center for Medical Research
Atlanta, Georgia
CenExel iResearch
Decatur, Georgia
Denali Health Atlanta, LLC
Stone Mountain, Georgia
Advanced Quality Medical Research
Orland Park, Illinois
Lumina Clinical Research Center
Cherry Hill, New Jersey
Neurobehavioral Research Inc
Cedarhurst, New York
Lehigh Center for Clinical Research
Allentown, Pennsylvania
Clinical Neuroscience Solutions, LLC
Memphis, Tennessee
Grayline Research Center
Wichita Falls, Texas
Core Clinical Research
Everett, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.